Back to LYEL
VANGUARD CAPITAL MANAGEMENT LLC → LYEL
VANGUARD CAPITAL MANAGEMENT LLC LYEL Position History
Lyell Immunopharma, Inc. • Healthcare
Quarters held
4
Latest value
$7.3M
Q3 2026
Peak value
$14.4M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $14.4M |
| Q1 2026 | $14.4M |
| Q2 2026 | $11.1M |
| Q3 2026 | $7.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $7.3M | 748.8K | — | — |
| Q2 2026 | $11.1M | 786.8K | — | — |
| Q1 2026 | $14.4M | 718.2K | — | — |
| Q1 2026 | $14.4M | 718.2K | — | — |
Other funds holding LYEL
$46.6M
$30.3M
$23.2M